Avoid unregulated research peptides, and let a healthcare provider weigh your medical history, goals, and insurance before you commit to either path
Monotherapy with GLP-1 receptor agonist, lixisenatide, significantly improves glycaemic control in type 2 diabetic patients [abstract 830]
There is no one-size-fits-all answer for how to microdose semaglutide or tirzepatide, and each protocol must be carefully individualized based on patient assessment and metabolic factors
The Fly in the Ointment Availability Does there always have to be a fly in the ointment
329,330 In degenerative joint diseases like OA, the metabolic balance of chondrocytes is disrupted, leading to the overproduction of degrading enzymes and inflammatory mediators, including iNOS, MMP-13, and ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5), which participate in cartilage degradation and inflammatory processes
Compoundingthe process by which pharmacies and other manufacturers alters the formulation FDA-approved drugs, a practice sanctioned by Congress in times of drug shortageshas recently become a flashpoint for the industry and regulators
